Judge OKs Glaxo's $65M Settlement Of Antitrust Suit Over Paxil Patent Gaming
A federal judge has approved SmithKline Beecham's $65 million settlement of a class-action antitrust suit brought by consumers who accused the U.K. drug maker of filing "sham" patent lawsuits to delay...To view the full article, register now.
Already a subscriber? Click here to view full article